State Ophthalmology seminar organised in Kannur

October 16, 2022 09:08 pm | Updated 09:10 pm IST - KANNUR

Ethambutol used in treatment of tuberculosis can cause blindness, said Sreeni Edakhlon, Chairman, Scientific Committee of Kerala Society of Ophthalmic Surgeons (KSOS).

He was speaking at the State Ophthalmology seminar ‘Ophthalmology Decoded’ held at E.K. Nayanar Academy here, organised under the aegis of KSOS, Comtrust Charitable Trust Eye Hospital, Ophthalmological Society of Kannur, and Indian Medical Association, Thalassery, on Sunday.

The conference was inaugurated by Speaker of the Kerala Legislative Assembly A.N. Shamseer.

Dr. Edakhlon said it was the higher dosage of Ethambutol that was causing vision loss. But, this high dose is necessary to manage multi-drug resistant tuberculosis. He also said that rheumatological diseases, if untreated, can lead to loss of vision.

Further, he said that glaucoma is an important cause of irreversible blindness. Since this a silent blinding condition without pain, and the patient doesn’t recognise the loss until the situation worsens, everyone should do an eye check up at least by the age of 40, he said, adding that treatment can preserve the residual vision effectively.

Ganesh V. Raman from Aravind Eye Hospital, Coimbatore, V.A. Jaison from Jyothis Eye Care, Kannur, Minu Mathan from Chaithanya Eye Hospital Trivandrum , Gopal S. Pillai from Amritha Institute of Medical Sciences, Bindu S. Ajith and Vijayalakshmi from Comtrust Eye Hospital, Kozhikode, chaired the sessions.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.